Sensei Biotherapeutics, Inc. (SNSE) Social Stream
SENSEI BIOTHERAPEUTICS INC (SNSE) Price Targets From Analysts
Use the tables below to see what analysts covering SENSEI BIOTHERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 2 | $12 | $12 | $12 | $0.69 | 1639.13% |
| 2022-03-10 | 3 | $12 | $10 | $11 | $0.69 | 1494.2% |
| 2022-05-11 | 3 | $12 | $4 | $8 | $0.69 | 1059.42% |
| 2022-08-09 | 2 | $4 | $4 | $4 | $0.69 | 479.71% |
| 2022-10-03 | 2 | $5 | $4 | $4.5 | $0.69 | 552.17% |
| 2022-12-09 | 2 | $4 | $4 | $4 | $0.69 | 479.71% |
| 2023-01-05 | 2 | $6 | $4 | $4.666 | $0.69 | 576.23% |
| 2023-09-27 | 3 | $6 | $4 | $5 | $0.69 | 624.64% |
| 2023-12-04 | 3 | $6 | $4 | $4.666 | $0.69 | 576.23% |
The Trend in the Analyst Price Target
SNSE's average price target has moved down $8 over the prior 29 months.
Over the past 51 weeks, SNSE's average upside potential has been 282.82%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-09 | 3 | 4 | 4 | 4.000 | 1.61 | 148.45% |
| 2023-01-05 | 2 | 6 | 4 | 4.666 | 1.50 | 211.07% |
| 2023-03-21 | 3 | 6 | 4 | 4.666 | 1.42 | 228.59% |
| 2023-08-04 | 2 | 6 | 4 | 5.000 | 1.22 | 309.84% |
| 2023-09-27 | 2 | 6 | 4 | 5.000 | 0.79 | 532.91% |
SNSE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 25 months, SNSE's average broker recommendation rating improved by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how SENSEI BIOTHERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1343.47% of that group.
- To contextualize these metrics, consider that out of all US stocks, SENSEI BIOTHERAPEUTICS INC's number of analysts covering the stock is higher than 100.22% of them.
- SENSEI BIOTHERAPEUTICS INC's average analyst price target is greater than 127.84% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SENSEI BIOTHERAPEUTICS INC's variance in analysts' estimates is lower than -231.55% of them.
Stocks similar to SENSEI BIOTHERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PHVS, ADAG, and LGVN.
View All Top Stocks by Price Target
Is SNSE a Buy, Hold or Sell? See the POWR Ratings now!